Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alex Alexopoulos"'
Autor:
Alex Alexopoulos, Maria Dakoutrou, Lamprini Nasi, Ioanna Thanopoulou, Talia Kakourou, Louiza Kontara, Nikolaos Douladiris, Maria Galani, Paraskevi Xepapadaki, Chrysoula Doxani, Theodoros Mprotsis, Elias Zintzaras, Nikolaos G. Papadopoulos, Christina Kanaka‐Gantenbein, George P. Chrousos
Publikováno v:
Pediatric Dermatology. 40:78-83
Ectoine is a widespread osmolyte enabling halophilic bacteria to withstand high osmotic stress that has many potential applications ranging from cosmetics to its use as a therapeutic agent.The aim of this study was to compare the efficacy and tolerab
Autor:
Irene Lara-Corrales, Alex Alexopoulos, Ulrike Blume-Peytavi, Lluís Puig, Wynnis L. Tom, Kelly M. Cordoro, Kristen E. Holland, Marieke M B Seyger, Emmanuel Mahé, Dennis P. West, Ruth Ann Vleugels, Ulrich Mrowietz, Leah Belazarian, Ruth Murphy, Marcia Hogeling, Claus Zachariae, Wietske Kievit, Amy S. Paller, Megha M. Tollefson, Inge M G J Bronckers, Jo Lambert, Zsuzsanna Szalai, Elaine C. Siegfried
Publikováno v:
JAMA DERMATOLOGY
Jama Dermatology, 156, 384-392
JAMA Dermatol
Bronckers, I M G J, Paller, A S, West, D P, Lara-Corrales, I, Tollefson, M M, Tom, W L, Hogeling, M, Belazarian, L, Zachariae, C, Mahé, E, Siegfried, E, Blume-Peytavi, U, Szalai, Z, Vleugels, R A, Holland, K, Murphy, R, Puig, L, Cordoro, K M, Lambert, J, Alexopoulos, A, Mrowietz, U, Kievit, W & Seyger, M M B 2020, ' A Comparison of Psoriasis Severity in Pediatric Patients Treated with Methotrexate vs Biologic Agents ', JAMA Dermatology, vol. 156, no. 4, pp. 384-392 . https://doi.org/10.1001/jamadermatol.2019.4835
Jama Dermatology, 156, 4, pp. 384-392
Jama Dermatology, 156, 384-392
JAMA Dermatol
Bronckers, I M G J, Paller, A S, West, D P, Lara-Corrales, I, Tollefson, M M, Tom, W L, Hogeling, M, Belazarian, L, Zachariae, C, Mahé, E, Siegfried, E, Blume-Peytavi, U, Szalai, Z, Vleugels, R A, Holland, K, Murphy, R, Puig, L, Cordoro, K M, Lambert, J, Alexopoulos, A, Mrowietz, U, Kievit, W & Seyger, M M B 2020, ' A Comparison of Psoriasis Severity in Pediatric Patients Treated with Methotrexate vs Biologic Agents ', JAMA Dermatology, vol. 156, no. 4, pp. 384-392 . https://doi.org/10.1001/jamadermatol.2019.4835
Jama Dermatology, 156, 4, pp. 384-392
This cohort study compares the use of methotrexate vs biologic agents in children with moderate to severe psoriasis. Question What is the association between use of methotrexate vs biologics and psoriasis severity and drug survival (rate and duration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9a96b13cb5b45718775ade78f5cf76
https://biblio.ugent.be/publication/8660999
https://biblio.ugent.be/publication/8660999
Publikováno v:
Pediatric Dermatology. 31:125-130
A growing number of dermatologists dispute the existence of infantile seborrheic dermatitis (ISD) as an independent clinical entity. Therefore the aim of the present study was to estimate the epidemiologic features of ISD in a defined population of G
Autor:
George P. Chrousos, Alex Alexopoulos
Publikováno v:
Reviews in endocrinemetabolic disorders. 17(3)
Emerging research has suggested that the skin is not only a target of organismal distress but also an active participant of the stress response through production of local “HPA axis” components, peripheral nerve endings, and resident skin cells,
Autor:
Ulrich Mrowietz, Zsuzsanna Szalai, Megha M. Tollefson, Irene Lara-Corrales, Inge M G J Bronckers, Ruth Murphy, Sandra Philipp, Wynnis L. Tom, Kelly M. Cordoro, Emmanuel Mahé, Jo Lambert, Eulalia Baselga, Amy S. Paller, Ruth Ann Vleugels, Dennis P. West, Marcia Hogeling, Claus Zachariae, Wietske Kievit, Elaine C. Siegfried, Leah Belazarian, Marieke M B Seyger, Kristen E. Holland, Alex Alexopoulos
Publikováno v:
Jama Dermatology, 153, 11, pp. 1147-1157
Jama Dermatology, 153, 1147-1157
Jama Dermatology, 153, 1147-1157
Importance Use of systemic therapies for moderate to severe psoriasis in children is increasing, but comparative data on their use and toxicities are limited. Objective To assess patterns of use and relative risks of systemic agents for moderate to s